This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

IVC, CVS, Medivet, others to see profits scrutinized in UK vets-for-pets market review

By Jon Menon ( November 1, 2024, 13:58 GMT | Insight) -- IVC Evidensia, CVS Group and four other major providers of pet veterinary services will see their profitability assessed by the UK antitrust regulator in its ongoing market investigation. The six have a combined share of almost 60 percent, the Competition and Markets Authority said. Interested parties have until Nov. 22 to respond to a working paper published today.IVC Evidensia, CVS Group and Medivet are among companies that will see their profitability assessed by the UK antitrust regulator as it probes the market for veterinary services for household pets....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections